NCT06642324

Brief Summary

Head and neck squamous cell carcinoma (HNSCC) represents a significant public health burden in Bangladesh with a high incidence and mortality rate. While traditional risk factors like tobacco and betel nut chewing contribute to HNSCC incidence, the emergence of HPV-associated HNSCC presents a unique challenge. The main goal of this observational study is to explore the prevalence, risk factors, and biological mechanisms underlying food habits and HPV-driven HNSCC in the population and identify the genomic changes and characteristics related to this malignancy. This study will provide the prevalence of HPV-associated HNSCC and screening the HPV typing in the Bangladeshi population, identify risk factors, and any biologically driven mechanisms causing HNSCC.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
550

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 12, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

December 31, 2024

Status Verified

December 1, 2024

Enrollment Period

11 months

First QC Date

October 12, 2024

Last Update Submit

December 28, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • HPV positivity in histopathological positive HNSCC detected tissue samples

    To detect and type the HPV DNA in HNSCC tissue samples utilizing Real-Time PCR and Histopathology.

    2 years

Secondary Outcomes (1)

  • Genetic predisposition to HNSCC due to virus, Food habit or Tobacco

    2 years

Study Arms (3)

HPV Positive HNSCC Population

Tissues from Head Neck Squamous Cell Carcinoma and HPV DNA-positive

Diagnostic Test: Histopathology, Immunohistochemistry, Real-Time PCR, Sequencing

HPV Negative HNSCC Population

Tissues from Head Neck Squamous Cell Carcinoma and HPV DNA-negative

Diagnostic Test: Histopathology, Immunohistochemistry, Real-Time PCR, Sequencing

Healthy Population

Healthy Population who does not have any carcinoma, chronic diseases, Genetic diseases, acute/chronic infectious diseases, etc.

Diagnostic Test: Histopathology, Immunohistochemistry, Real-Time PCR, Sequencing

Interventions

Histopathology for carcinoma detection, Immunohistochemistry for carcinoma-related protein expression, Real-Time PCR for HPV association and HPV typing, Sequencing for genetic study or mutation analysis.

HPV Negative HNSCC PopulationHPV Positive HNSCC PopulationHealthy Population

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A descriptive study will be conducted among head-neck squamous cell carcinoma people, who will be recruited after receiving informed written consent to participate. The study population will be recruited from the Department of Otolaryngology-Head \& Neck Surgery, histopathology of the BSMMU, and laboratory work will be done at the Department of Virology, BSMMU. During the specimen collection, brief demographic and clinical data will be collected through a pre-designed written questionnaire.

You may qualify if:

  • Patient Age: adult (\> 18 years)
  • Head and neck squamous cell carcinoma diagnosed by biopsy (Histopathology confirmed HNSCC).
  • Diagnosed cases specific Head-Neck sub-sites: (oral cavity, oropharynx, hypopharynx, larynx, tongue)
  • Patient's Consent

You may not qualify if:

  • Patient Age: children (\< 18 years)
  • Cancers of any part of the body other than the head-neck region.
  • People without HNSCC
  • Any chronic diseases, genetic diseases, acute/chronic infectious diseases, etc. -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bangabandhu Sheikh Mujib Medical University (BSMMU)

Dhaka, Dhaka Division, 1000, Bangladesh

RECRUITING

Related Publications (4)

  • Akhter M, Ali L, Hassan Z, Khan I. Association of human papilloma virus infection and oral squamous cell carcinoma in Bangladesh. J Health Popul Nutr. 2013 Mar;31(1):65-9. doi: 10.3329/jhpn.v31i1.14750.

    PMID: 23617206BACKGROUND
  • Gao G, Wang J, Kasperbauer JL, Tombers NM, Teng F, Gou H, Zhao Y, Bao Z, Smith DI. Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas. BMC Cancer. 2019 Apr 11;19(1):352. doi: 10.1186/s12885-019-5536-1.

    PMID: 30975103BACKGROUND
  • Lechner M, Frampton GM, Fenton T, Feber A, Palmer G, Jay A, Pillay N, Forster M, Cronin MT, Lipson D, Miller VA, Brennan TA, Henderson S, Vaz F, O'Flynn P, Kalavrezos N, Yelensky R, Beck S, Stephens PJ, Boshoff C. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Med. 2013 May 29;5(5):49. doi: 10.1186/gm453. eCollection 2013.

    PMID: 23718828BACKGROUND
  • Shaikh MH, Khan AI, Sadat A, Chowdhury AH, Jinnah SA, Gopalan V, Lam AK, Clarke DTW, McMillan NAJ, Johnson NW. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh. BMC Cancer. 2017 Nov 25;17(1):792. doi: 10.1186/s12885-017-3789-0.

    PMID: 29178862BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Biopsy sample, Mouth wash, whole blood, serum, paraffin embedded tissue

MeSH Terms

Conditions

Head and Neck NeoplasmsOropharyngeal Neoplasms

Interventions

ImmunohistochemistryBase Sequence

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsPharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsPharyngeal DiseasesStomatognathic DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

HistocytochemistryCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHistological TechniquesInvestigative TechniquesImmunologic TechniquesMolecular StructureBiochemical PhenomenaChemical PhenomenaGenetic StructuresGenetic Phenomena

Study Officials

  • S M Rashed Ul Islam, M. Phil, MPH

    Bangabandhu Sheikh Mujib Medical University (BSMMU)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

S M Rashed Ul Islam, M. Phil, MPH

CONTACT

Syed Farhan Ali Razib, FCPS

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 12, 2024

First Posted

October 15, 2024

Study Start

April 30, 2024

Primary Completion

March 30, 2025

Study Completion

September 30, 2025

Last Updated

December 31, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations